← Open Payments lookup

STEVEN KALFUS: Open Payments

NPI 1801938865 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,587 in 138 payments from 22 companies in 2025. Trend: 2023 $7,770 · 2024 $9,558 · 2025 $3,587

Food & beverage: $2,687Speaker / faculty: $900
CompanyPaymentsAmount
Ipsen Biopharmaceuticals, Inc15$1,239
ABBVIE INC.27$574
Gilead Sciences, Inc.15$345
Salix Pharmaceuticals, a division of Bausch Health US, LLC20$232
Madrigal Pharmaceuticals12$198
QOL Medical, LLC8$167
Ardelyx, Inc.8$148
Aimmune Therapeutics, Inc.6$140
Takeda Pharmaceuticals U.S.A., Inc.6$113
GENZYME CORPORATION4$82

Products named: IQIRVO, MAVYRET, REZDIFFRA, Sucraid, CREON, IBSRELA, XIFAXAN, DUPIXENT.

Industry payments across AZ — which companies pay providers there.